AU6514296A - Heterocyclic compounds, their preparation and use - Google Patents
Heterocyclic compounds, their preparation and useInfo
- Publication number
- AU6514296A AU6514296A AU65142/96A AU6514296A AU6514296A AU 6514296 A AU6514296 A AU 6514296A AU 65142/96 A AU65142/96 A AU 65142/96A AU 6514296 A AU6514296 A AU 6514296A AU 6514296 A AU6514296 A AU 6514296A
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK87095 | 1995-07-31 | ||
DK870/95 | 1995-07-31 | ||
PCT/DK1996/000332 WO1997005109A1 (fr) | 1995-07-31 | 1996-07-31 | Composes heterocycliques, leur preparation et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6514296A true AU6514296A (en) | 1997-02-26 |
Family
ID=8098461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU65142/96A Abandoned AU6514296A (en) | 1995-07-31 | 1996-07-31 | Heterocyclic compounds, their preparation and use |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0843660A1 (fr) |
JP (1) | JPH11509847A (fr) |
AU (1) | AU6514296A (fr) |
WO (1) | WO1997005109A1 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW544448B (en) | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
DE19801636A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte bicyclische Lactone |
DE19801647A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte beta,gamma-annellierte Lactone |
DE19801646A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte alpha,beta-annellierte Butyrolactone |
AU2241400A (en) | 1999-04-06 | 2000-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | Novel thiazolobenzoimidazole derivative |
DE60009116T2 (de) | 1999-10-15 | 2005-02-17 | F. Hoffmann-La Roche Ag | Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten |
PT1224174E (pt) * | 1999-10-15 | 2004-01-30 | Hoffmann La Roche | Derivados de benzodiazepina como antagonistas do receptor metabotropico do glutamato |
CA2580221A1 (fr) * | 2004-10-05 | 2006-04-13 | Merz Pharma Gmbh & Co. Kgaa | Nouvelles propenones cycliques et acycliques destinees au traitement des troubles du snc |
KR20080023680A (ko) | 2005-05-10 | 2008-03-14 | 인터뮨, 인크. | 스트레스-활성화 단백질 키나제 시스템을 조절하기 위한피리돈 유도체 |
EP2578216A1 (fr) | 2006-11-22 | 2013-04-10 | Seaside Therapeutics, Inc. | Procédés de traitement du syndrome de l'X fragile |
BRPI0810655A2 (pt) | 2007-04-19 | 2014-11-04 | Hoffmann La Roche | Derivados de di-hidro-benzo[b][1,4] diazepin-2-ona sulfonamida |
MX2010012848A (es) | 2008-06-03 | 2011-03-01 | Intermune Inc | Compuestos y metodos para tratar trastornos inflamatorios y fibroticos. |
WO2011109398A2 (fr) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Procédés et compositions pour le traitement du syndrome d'angelman et des troubles du spectre autistique |
US20110294879A1 (en) | 2010-05-28 | 2011-12-01 | Xenoport, Inc. | Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders |
WO2012009646A1 (fr) | 2010-07-15 | 2012-01-19 | Xenoport, Inc. | Méthodes de traitement du syndrome de l'x fragile, du syndrome de down, de l'autisme et de troubles associés |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
CN106459042B (zh) | 2014-04-02 | 2019-06-28 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
EP3455207A4 (fr) * | 2016-05-12 | 2019-10-09 | Regents of the University of Minnesota | Composés indole et indazole cyanocinnamate et leurs utilisations thérapeutiques |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3931230A (en) * | 1974-04-12 | 1976-01-06 | Warner-Lambert Company | 3-Substituted isotryptamine derivatives and process for their production |
KR0178469B1 (ko) * | 1990-07-16 | 1999-03-20 | 메이나드 알. 존슨 | 흥분성 아미노산 길항제 |
US5284862A (en) * | 1991-03-18 | 1994-02-08 | Warner-Lambert Company | Derivatives of 2-carboxyindoles having pharmaceutical activity |
-
1996
- 1996-07-31 JP JP9507124A patent/JPH11509847A/ja active Pending
- 1996-07-31 AU AU65142/96A patent/AU6514296A/en not_active Abandoned
- 1996-07-31 WO PCT/DK1996/000332 patent/WO1997005109A1/fr not_active Application Discontinuation
- 1996-07-31 EP EP96924801A patent/EP0843660A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JPH11509847A (ja) | 1999-08-31 |
EP0843660A1 (fr) | 1998-05-27 |
WO1997005109A1 (fr) | 1997-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6514196A (en) | Heterocyclic compounds, their preparation and use | |
AU1106195A (en) | Heterocyclic compounds, their preparation and use | |
AU6124196A (en) | Novel dolastatin derivatives, their preparation and use | |
AU4009795A (en) | Heterocyclic compounds and their use | |
AU7550398A (en) | Heterocyclic compounds, their production and use | |
AU6514296A (en) | Heterocyclic compounds, their preparation and use | |
AU4329396A (en) | Use of 3,4-diphenylchromans | |
AU679887B2 (en) | Azole derivatives, their use, production and usage | |
AU6016896A (en) | Heterocyclic compounds, their production and use | |
AU7095296A (en) | Phosphorylamides, their preparation and use | |
AU6658596A (en) | Substituted 1-phenyluracil derivatives, their preparation and their use as herbicides | |
AU1504495A (en) | Substituted heterocyclic carboxamidoesters, their preparation and their use as pharmaceuticals | |
AU4675596A (en) | Azole compounds, their production and use | |
AU4509696A (en) | 3-benzoylpyridine derivatives, their preparation and their use as herbicides | |
AU3467697A (en) | 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same | |
AU1081897A (en) | Heterocyclic compounds and their use | |
AU2030197A (en) | 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof | |
AU2563895A (en) | 4-benzoylisoxazole derivatives and their use as herbicides | |
AU3650695A (en) | New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use | |
AU7001396A (en) | Triazole compounds, their production and use | |
AU5557698A (en) | Novel calpaines, their preparation and use | |
AU2152497A (en) | Heterocyclic compounds and their preparation and use | |
AU5272296A (en) | Benzopyranopyrrole compounds, their preparation and use | |
AU5815696A (en) | N-aminopyridone derivatives and their use as herbicides | |
AU6298196A (en) | Tetrahydro-betacarboline derivatives and their preparation and use |